Peripheral Neuropathy
June 2017 Issue
 
 
 

Nearly every major medical breakthrough over the past 50 years can be attributed to new discoveries that were made possible through meticulous biomedical research. Many diseases and conditions that previously took a heavy toll on patients in terms of both morbidity and mortality are now either treatable or preventable thanks in large part to painstaking research that expanded the frontiers of scientific knowledge and moved the most promising basic research developments into tangible health benefits through human clinical trails. Ongoing research is also the key that will open the door to additional major medical advances and breakthroughs in the future.

Our staff at Medifocus is committed to keeping our subscribers to the Medifocus Digest Alert on Peripheral Neuropathy abreast of the latest new research developments that have recently been published in the medical literature for this condition. In this issue of the Digest Alert, you will find a focused list of hand-picked journal article references that represent the latest advances in basic and clinical research for Peripheral Neuropathy. These articles represent the current state-of-the-art of the research that will hopefully lead to additional major advances and breakthroughs in the clinical management of Peripheral Neuropathy. You can access the summaries of each article referenced below by simply clicking on the article Title.

We will continue to update you with the latest scientific and clinical developments through the Medifocus Digest Alert on Peripheral Neuropathy every 3 months. Thank you for your ongoing subscription to this publication.

Sincerely,
Elliot Jacob, Ph.D.
Vice-President - Content
Medifocus.com, Inc.



1:Update on Chemotherapy-Induced Peripheral Neuropathy.
Authors:Cioroiu C, Weimer LH
Institution:Neurological Institute of New York, Columbia University Medical Center, 710 W168th Street, New York, NY, 10032, USA. W168th Street, New York, NY, 10032, USA. lhw1@cumc.columbia.edu.
Journal:Curr Neurol Neurosci Rep. 2017 Jun;17(6):47. doi: 10.1007/s11910-017-0757-7.

2:Anemia, bilirubin, and cardiovascular autonomic neuropathy in patients with type 2 diabetes.
Authors:Chung JO, Park SY, Cho DH, Chung DJ, Chung MY
Institution:aDivision of Endocrinology and Metabolism bDivision of Gastroenterology and Hepatology, Department of Internal Medicine, Chonnam National University Medical School, Gwangju, Republic of Korea.
Journal:Medicine (Baltimore). 2017 Apr;96(15):e6586. doi: 10.1097/MD.0000000000006586.

3:Pharmacotherapy for diabetic peripheral neuropathy pain and quality of life: A systematic review.
Authors:Waldfogel JM, Nesbit SA, Dy SM, Sharma R, Zhang A, Wilson LM, Bennett WL, Yeh HC, Chelladurai Y, Feldman D, Robinson KA
Institution:From the Department of Pharmacy (J.M.W., S.A.N.), The Johns Hopkins Hospital; Department of Health Policy & Management (S.M.D., R.S., A.Z., L.M.W.), Johns Hopkins Bloomberg School of Public Health; Division of General Internal Medicine (W.L.B., K.A.R.) and Department of Physical Medicine & Rehabilitation (D.F.), Johns Hopkins University School of Medicine; Departments of Medicine, Epidemiology, and Oncology (H.-C.Y.), Division of General Internal Medicine, Johns Hopkins University, Baltimore, MD; and Department of Internal Medicine (Y.C.), Morehouse School of Medicine, Atlanta, GA. Jwaldfo2@jhmi.edu. Department of Health Policy & Management (S.M.D., R.S., A.Z., L.M.W.), Johns Hopkins Bloomberg School of Public Health; Division of General Internal Medicine (W.L.B., K.A.R.) and Department of Physical Medicine & Rehabilitation (D.F.), Johns Hopkins University School of Medicine; Departments of Medicine, Epidemiology, and Oncology (H.-C.Y.), Division of General Internal Medicine, Johns Hopkins University, Baltimore, MD; and Department of Internal Medicine (Y.C.), Morehouse School of Medicine, Atlanta, GA. Department of Health Policy & Management (S.M.D., R.S., A.Z., L.M.W.), Johns Hopkins Bloomberg School of Public Health; Division of General Internal Medicine (W.L.B., K.A.R.) and Department of Physical Medicine & Rehabilitation (D.F.), Johns Hopkins University School of Medicine; Departments of Medicine, Epidemiology, and Oncology (H.-C.Y.), Division of General Internal Medicine, Johns Hopkins University, Baltimore, MD; and Department of Internal Medicine (Y.C.), Morehouse School of Medicine, Atlanta, GA. Department of Health Policy & Management (S.M.D., R.S., A.Z., L.M.W.), Johns Hopkins Bloomberg School of Public Health; Division of General Internal Medicine (W.L.B., K.A.R.) and Department of Physical Medicine & Rehabilitation (D.F.), Johns Hopkins University School of Medicine; Departments of Medicine, Epidemiology, and Oncology (H.-C.Y.), Division of General Internal Medicine, Johns Hopkins University, Baltimore, MD; and Department of Internal Medicine (Y.C.), Morehouse School of Medicine, Atlanta, GA. Department of Health Policy & Management (S.M.D., R.S., A.Z., L.M.W.), Johns Hopkins Bloomberg School of Public Health; Division of General Internal Medicine (W.L.B., K.A.R.) and Department of Physical Medicine & Rehabilitation (D.F.), Johns Hopkins University School of Medicine; Departments of Medicine, Epidemiology, and Oncology (H.-C.Y.), Division of General Internal Medicine, Johns Hopkins University, Baltimore, MD; and Department of Internal Medicine (Y.C.), Morehouse School of Medicine, Atlanta, GA. Department of Health Policy & Management (S.M.D., R.S., A.Z., L.M.W.), Johns Hopkins Bloomberg School of Public Health; Division of General Internal Medicine (W.L.B., K.A.R.) and Department of Physical Medicine & Rehabilitation (D.F.), Johns Hopkins University School of Medicine; Departments of Medicine, Epidemiology, and Oncology (H.-C.Y.), Division of General Internal Medicine, Johns Hopkins University, Baltimore, MD; and Department of Internal Medicine (Y.C.), Morehouse School of Medicine, Atlanta, GA. Department of Health Policy & Management (S.M.D., R.S., A.Z., L.M.W.), Johns Hopkins Bloomberg School of Public Health; Division of General Internal Medicine (W.L.B., K.A.R.) and Department of Physical Medicine & Rehabilitation (D.F.), Johns Hopkins University School of Medicine; Departments of Medicine, Epidemiology, and Oncology (H.-C.Y.), Division of General Internal Medicine, Johns Hopkins University, Baltimore, MD; and Department of Internal Medicine (Y.C.), Morehouse School of Medicine, Atlanta, GA. Department of Health Policy & Management (S.M.D., R.S., A.Z., L.M.W.), Johns Hopkins Bloomberg School of Public Health; Division of General Internal Medicine (W.L.B., K.A.R.) and Department of Physical Medicine & Rehabilitation (D.F.), Johns Hopkins University School of Medicine; Departments of Medicine, Epidemiology, and Oncology (H.-C.Y.), Division of General Internal Medicine, Johns Hopkins University, Baltimore, MD; and Department of Internal Medicine (Y.C.), Morehouse School of Medicine, Atlanta, GA. Department of Health Policy & Management (S.M.D., R.S., A.Z., L.M.W.), Johns Hopkins Bloomberg School of Public Health; Division of General Internal Medicine (W.L.B., K.A.R.) and Department of Physical Medicine & Rehabilitation (D.F.), Johns Hopkins University School of Medicine; Departments of Medicine, Epidemiology, and Oncology (H.-C.Y.), Division of General Internal Medicine, Johns Hopkins University, Baltimore, MD; and Department of Internal Medicine (Y.C.), Morehouse School of Medicine, Atlanta, GA. Department of Health Policy & Management (S.M.D., R.S., A.Z., L.M.W.), Johns Hopkins Bloomberg School of Public Health; Division of General Internal Medicine (W.L.B., K.A.R.) and Department of Physical Medicine & Rehabilitation (D.F.), Johns Hopkins University School of Medicine; Departments of Medicine, Epidemiology, and Oncology (H.-C.Y.), Division of General Internal Medicine, Johns Hopkins University, Baltimore, MD; and Department of Internal Medicine (Y.C.), Morehouse School of Medicine, Atlanta, GA. Department of Health Policy & Management (S.M.D., R.S., A.Z., L.M.W.), Johns Hopkins Bloomberg School of Public Health; Division of General Internal Medicine (W.L.B., K.A.R.) and Department of Physical Medicine & Rehabilitation (D.F.), Johns Hopkins University School of Medicine; Departments of Medicine, Epidemiology, and Oncology (H.-C.Y.), Division of General Internal Medicine, Johns Hopkins University, Baltimore, MD; and Department of Internal Medicine (Y.C.), Morehouse School of Medicine, Atlanta, GA.
Journal:Neurology. 2017 May 16;88(20):1958-1967. doi: 10.1212/WNL.0000000000003882. Epub 2017 Mar 24.

4:Lipids: A Suitable Therapeutic Target in Diabetic Neuropathy?
Authors:Perez-Matos MC, Morales-Alvarez MC, Mendivil CO
Institution:School of Medicine, Universidad de Los Andes, Bogota, Colombia.
Journal:J Diabetes Res. 2017;2017:6943851. doi: 10.1155/2017/6943851. Epub 2017 Jan 16.

5:Assessment of the characteristics and quality of life of patients with uremic peripheral neuropathy.
Authors:Yu XZ, Lu S, Gou W, Wang W, Zou SH, Han YX, Wang WW, Zhang JY
Journal:Clin Nephrol. 2017 Mar;87 (2017)(3):134-139. doi: 10.5414/CN108913.

6:Clinical effectiveness of low-level laser treatment on peripheral somatosensory neuropathy.
Authors:Fallah A, Mirzaei A, Gutknecht N, Demneh AS
Institution:AALZ, Aachen, Germany. reza_aria82@hotmail.com.
Journal:Lasers Med Sci. 2017 Apr;32(3):721-728. doi: 10.1007/s10103-016-2137-y. Epub 2017 Jan 10.

7:Diabetic peripheral neuropathy and prevalence of erectile dysfunction in Japanese patients aged <65 years with type 2 diabetes mellitus: The Dogo Study.
Authors:Furukawa S, Sakai T, Niiya T, Miyaoka H, Miyake T, Yamamoto S, Maruyama K, Ueda T, Senba H, Todo Y, Torisu M, Minami H, Onji M, Tanigawa T, Matsuura B, Hiasa Y, Miyake Y
Institution:Department of Epidemiology and Preventive Medicine, Ehime University Graduate School of Medicine, Shitsukawa, Toon, Japan. University Hospital, Shitsukawa, Toon, Japan. Japan. Japan. of Medicine, Shitsukawa, Toon, Japan. Graduate School of Medicine, Shitsukawa, Toon, Japan. Tokyo, Japan. Japan. School of Medicine, Shitsukawa, Toon, Japan. of Medicine, Shitsukawa, Toon, Japan. Japan. Tokyo, Japan. Graduate School of Medicine, Shitsukawa, Toon, Japan. of Medicine, Shitsukawa, Toon, Japan. School of Medicine, Shitsukawa, Toon, Japan. University Hospital, Shitsukawa, Toon, Japan.
Journal:Int J Impot Res. 2017 Jan;29(1):30-34. doi: 10.1038/ijir.2016.40. Epub 2016 Oct 27.

8:Peripheral neuropathy in the hands of people with diabetes mellitus.
Authors:Ennis SL, Galea MP, O'Neal DN, Dodson MJ
Institution:School of Medicine, University of Notre Dame, Australia. Electronic address: samantha.ennis1@my.nd.edu.au. Parkville, Victoria 3010, Australia. Electronic address: m.galea@unimelb.edu.au. 4th Floor Clinical Sciences Building, Fitzroy, Victoria 3065, Australia. Electronic address: dno@unimelb.edu.au.
Journal:Diabetes Res Clin Pract. 2016 Sep;119:23-31. doi: 10.1016/j.diabres.2016.06.010. Epub 2016 Jun 18.

9:Inflammation as a Therapeutic Target for Diabetic Neuropathies.
Authors:Pop-Busui R, Ang L, Holmes C, Gallagher K, Feldman EL
Institution:Department of Internal Medicine, Division of Metabolism, Metabolism Endocrinology and Diabetes, University of Michigan, 5329 Brehm Tower, 1000 Wall Street, Ann Arbor, MI, 48105, USA. rpbusui@umich.edu. and Diabetes, University of Michigan, 5329 Brehm Tower, 1000 Wall Street, Ann Arbor, MI, 48105, USA. ang@med.umich.edu. Suite 1300 24 Frank Lloyd Wright Drive, PO Box 451, Ann Arbor, MI, 48106-0451, USA. crysholm@med.umich.edu. System, 1500 East Medical Center Dr, SPC 5867, Ann Arbor, MI, 48109, USA. kgallag@med.umich.edu. Place, Ann Arbor, MI, 48109-2200, USA. efeldman@umich.edu.
Journal:Curr Diab Rep. 2016 Mar;16(3):29. doi: 10.1007/s11892-016-0727-5.

10:Small and large fiber neuropathy in those with type 1 and type 2 diabetes: a 5-year follow-up study.
Authors:Loseth S, Stalberg EV, Lindal S, Olsen E, Jorde R, Mellgren SI
Institution:Department of Neurology and Neurophysiology, University Hospital of North Norway, Tromso, Norway. Sweden. Norway. Norway. Tromso, Norway.
Journal:J Peripher Nerv Syst. 2016 Mar;21(1):15-21. doi: 10.1111/jns.12154.

11:People with diabetic peripheral neuropathy display a decreased stepping accuracy during walking: potential implications for risk of tripping.
Authors:Handsaker JC, Brown SJ, Bowling FL, Marple-Horvat DE, Boulton AJ, Reeves ND
Institution:School of Healthcare Science, Manchester Metropolitan University, Manchester, UK.
Journal:Diabet Med. 2016 May;33(5):644-9. doi: 10.1111/dme.12851. Epub 2015 Aug 20.

12:Pregabalin in Patients With Painful Diabetic Peripheral Neuropathy Using an NSAID for Other Pain Conditions: A Double-Blind Crossover Study.
Authors:Raskin P, Huffman C, Yurkewicz L, Pauer L, Scavone JM, Yang R, Parsons B
Institution:*Department of Medicine, University of Texas Southwestern Medical Center, Dallas, TX daggerMeridien Research, Tampa, FL double daggerPfizer Inc., Groton, CT section signPfizer Inc., New York, NY.
Journal:Clin J Pain. 2016 Mar;32(3):203-10. doi: 10.1097/AJP.0000000000000254.

13:Herbal medicines and chemotherapy induced peripheral neuropathy (CIPN): A critical literature review.
Authors:Schloss J, Colosimo M, Vitetta L
Institution:a The University of Queensland, The School of Medicine, Translational Research Institute, Princess Alexandra Hospital , Ipswich Road, Woolloongabba , Australia. Chermside , Australia.
Journal:Crit Rev Food Sci Nutr. 2017 Apr 13;57(6):1107-1118. doi: 10.1080/10408398.2014.889081.

For a FREE PREVIEW of the Medifocus Guidebook on Peripheral Neuropathy click here

To purchase a copy of the COMPLETE Medifocus Guidebook on Peripheral Neuropathy click here

To subscribe to additional FREE Medifocus Digest Alert on other disease/condition areas click here

  
Get the Medifocus Guidebook on Peripheral Neuropathy...
at a Special 20% Discount


Medifocus Guidebook on Peripheral Neuropathy

Updated: June 23, 2017
169 Pages

This one of a kind Guidebook offers:

  • Answers to your critical health questions including the latest treatments, clinical trials, and expert research.
     
  • High Quality, Professional level information you can trust and understand culled from the latest peer-reviewed journals.
     
  • Timely, up to date content with free guidebook updates for 1 year.
     
  • A unique resource to find leading experts, institutions, and support organizations including contact information and hyperlinks.
     
  • Over 130,000 Guidebooks Sold
     
  • 100% Risk Free Money Back Guarantee



ORDER THE GUIDEBOOK

The Medifocus Guidebook on Peripheral Neuropathy is available in the following two convenient formats:

PRINTED GUIDEBOOK

Soft-cover book that is available for immediate shipping via either U.S. Priority Mail or International AirMail (outside the U.S.).

  • Regular List Price = $36.95
  • Less 20% Discount = - $7.40
  • Discounted Price = $29.55(excluding shipping & handling)

Order the Printed Guidebook

DIGITAL GUIDEBOOK

Available for immediate download as a PDF document.

  • Regular List Price = $27.95
  • Less 20% Discount = - $5.60
  • Discounted Price = $22.35

Order the Digital Guidebook



Order by Phone

Call Toll Free in the U.S.
1-800-965-3002

From Outside the U.S.
1-301-649-9300

You can also receive a 20% discount when you order your Guidebook by phone.

To receive your 20% discount, simply mention the Discount Coupon Code below to the customer service representative taking your order.

Discount Coupon Code for
Phone Orders

PN32540921

Coupon Expires: August 25, 2017



What Our Customers Are Saying...

"This is the BEST informational and reference book pertaining to my long-time ailment 'Peripheral Neuropathy'. I have researched this relatively obscure subject for seven years. The MediFocus Guidebook on Peripheral Neuropathy is easy reading, concise, and contains great references."
H.S.
Bellevue, Nebraska


"Your very informative Guidebook helped me understand my Peripheral Neuropathy much better than my doctor had time to explain. Thank you."
P.S.
Midland, Texas


"I recently purchased your MediFocus Guidebook on Peripheral Neuropathy and found the information quite helpful in making decisions about the direction I wanted to take in dealing with my condition. Even after meeting with a Neurologist and being tested, I had many questions that he was unable to answer. We all have to take control of our own health care and the MediFocus Guidebook is a great tool for doing that."
J.H.
Seattle, Washington



  
Medifocus Digest Alert is published monthly by Medifocus, Inc.
6810 Park Heights Avenue, Suite C5, Baltimore, MD 21215 USA
Copyright © 2013 Medifocus, Inc. All rights reserved.